Citation Results
Targeted therapies: Goldie–Coldman and bevacizumab beyond disease progression
Nature Reviews Clinical Oncology 6, 311 - 312 (2009) | doi:10.1038/nrclinonc.2009.66.
Targeted therapies: Goldie–Coldman and bevacizumab beyond disease progression
Nature Reviews Clinical Oncology 6, 311 - 312 (2009) | doi:10.1038/nrclinonc.2009.66.